Please wait a minute...
Protein & Cell

ISSN 1674-800X

ISSN 1674-8018(Online)

CN 11-5886/Q

Postal Subscription Code 80-984

2018 Impact Factor: 7.575

Protein Cell    2019, Vol. 10 Issue (1) : 20-30    https://doi.org/10.1007/s13238-018-0556-1
SHORT ARTICLE
Rapid generation of gene-targeted EPS-derived mouse models through tetraploid complementation
Haibo Li1, Chaoran Zhao1, Jun Xu1, Yaxing Xu1, Chunmei Cheng4, Yinan Liu1, Ting Wang1, Yaqin Du1, Liangfu Xie1, Jingru Zhao3, Yanchuang Han4, Xiaobao Wang1, Yun Bai1(), Hongkui Deng1,2()
1. Department of Cell Biology, School of Basic Medical Sciences, Peking University Stem Cell Research Center, State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center and the MOE Key Laboratory of Cell Proliferation and Differentiation, College of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100191, China
2. Shenzhen Stem Cell Engineering Laboratory, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen 518055, China
3. Peking University-Tsinghua University-National Institute of Biological Sciences Joint Graduate Program, College of Life Sciences, Peking University, Beijing 100871, China
4. BeiHao Stem Cell and Regenerative Medicine Translational Research Institute, Beijing, China
 Download: PDF(3048 KB)  
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

One major strategy to generate genetically modified mouse models is gene targeting in mouse embryonic stem (ES) cells, which is used to produce gene-targeted mice for wide applications in biomedicine. However, a major bottleneck in this approach is that the robustness of germline transmission of gene-targeted ES cells can be significantly reduced by their genetic and epigenetic instability after long-term culturing, which impairs the efficiency and robustness of mouse model generation. Recently, we have established a new type of pluripotent cells termed extended pluripotent stem (EPS) cells, which have superior developmental potency and robust germline competence compared to conventional mouse ES cells. In this study, we demonstrate that mouse EPS cells well maintain developmental potency and genetic stability after long-term passage. Based on gene targeting in mouse EPS cells, we established a new approach to directly and rapidly generate gene-targeted mouse models through tetraploid complementation, which could be accomplished in approximately 2 months. Importantly, using this approach, we successfully constructed mouse models in which the human interleukin 3 (IL3) or interleukin 6 (IL6) gene was knocked into its corresponding locus in the mouse genome. Our study demonstrates the feasibility of using mouse EPS cells to rapidly generate mouse models by gene targeting, which have great application potential in biomedical research.

Keywords tetraploid complementation      EPS      mouse model      CRISPR/Cas9     
Corresponding Author(s): Yun Bai,Hongkui Deng   
Issue Date: 31 January 2019
 Cite this article:   
Haibo Li,Chaoran Zhao,Jun Xu, et al. Rapid generation of gene-targeted EPS-derived mouse models through tetraploid complementation[J]. Protein Cell, 2019, 10(1): 20-30.
 URL:  
https://academic.hep.com.cn/pac/EN/10.1007/s13238-018-0556-1
https://academic.hep.com.cn/pac/EN/Y2019/V10/I1/20
1 MCarido, YZhu, KPostel, BBenkner, PCimalla, MOKarl, TKurth, FPaquet-Durand, EKoch, TAMunchet al. (2014) Characterization of a mouse model with complete RPE loss and its use for RPE cell transplantation. Invest Ophthalmol Vis Sci 55:5431–5444
https://doi.org/10.1167/iovs.14-14325
2 JChoi, AJHuebner, KClement, RMWalsh, ASavol, KLin, HGu, BDi Stefano, JBrumbaugh, SYKimet al. (2017) Prolonged Mek1/2 suppression impairs the developmental potential of embryonic stem cells. Nature 548:219–223
https://doi.org/10.1038/nature23274
3 LCong, FARan, DCox, SLin, RBarretto, NHabib, PDHsu, XWu, WJiang, LAMarraffiniet al. (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339:819–823
https://doi.org/10.1126/science.1231143
4 ADoyle, MPMcGarry, NALee, JJLee (2012) The construction of transgenic and gene knockout/knockin mouse models of human disease. Transgenic Res 21:327–349
https://doi.org/10.1007/s11248-011-9537-3
5 MIto, HHiramatsu, KKobayashi, KSuzue, MKawahata, KHioki, YUeyama, YKoyanagi, KSugamura, KTsujiet al. (2002) NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100:3175–3182
https://doi.org/10.1182/blood-2001-12-0207
6 LLKenney, LDShultz, DLGreiner, MABrehm (2016) Humanized mouse models for transplant immunology. Am J Transplant 16:389–397
https://doi.org/10.1111/ajt.13520
7 TDLi, GHFeng, YFLi, MWang, JJMao, JQWang, XLi, XPWang, BQu, LYWanget al. (2017) Rat embryonic stem cells produce fertile offspring through tetraploid complementation. Proc Natl Acad Sci USA 114:11974–11979
https://doi.org/10.1073/pnas.1708710114
8 RNPlasschaert, MSBartolomei (2014) Genomic imprinting in development, growth, behavior and stem cells. Development 141:1805–1813
https://doi.org/10.1242/dev.101428
9 ARappaport, LJohnson (2014) Genetically engineered knock-in and conditional knock-in mouse models of cancer. Cold Spring Harb Protoc 2014:897–911
https://doi.org/10.1101/pdb.top069799
10 ARongvaux, HTakizawa, TStrowig, TWillinger, EEEynon, RAFlavell, MGManz (2013) Human hemato-lymphoid system mice: current use and future potential for medicine. Annu Rev Immunol 31:635–674
https://doi.org/10.1146/annurev-immunol-032712-095921
11 BTang, KDutt, LPapale, RRusconi, AShankar, JHunter, STufik, FHYu, WACatterall, MMantegazzaet al. (2009) A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS+) mutation. Neurobiol Dis 35:91–102
https://doi.org/10.1016/j.nbd.2009.04.007
12 IVisigalli, SDelai, LSPoliti, CDi Domenico, FCerri, EMrak, RD’Isa, DUngaro, MStok, FSanvitoet al. (2010) Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model. Blood 116:5130–5139
https://doi.org/10.1182/blood-2010-04-278234
13 TWillinger, ARongvaux, HTakizawa, GDYancopoulos, DMValenzuela, AJMurphy, WAuerbach, EEEynon, SStevens, MGManzet al. (2011) Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc Natl Acad Sci USA 108:2390–2395
https://doi.org/10.1073/pnas.1019682108
14 MYagi, SKishigami, ATanaka, KSemi, EMizutani, SWakayama, TWakayama, TYamamoto, YYamada (2017) Derivation of ground-state female ES cells maintaining gamete-derived DNA methylation. Nature 548:224–227
https://doi.org/10.1038/nature23286
15 HYang, HWang, RJaenisch (2014) Generating genetically modified mice using CRISPR/Cas-mediated genome engineering. Nat Protoc 9:1956–1968
https://doi.org/10.1038/nprot.2014.134
16 YYang, BLiu, JXu, JWang, JWu, CShi, YXu, JDong, CWang, WLaiet al. (2017) Derivation of pluripotent stem cells with in vivo embryonic and extraembryonic potency. Cell 169(243–257):e225
https://doi.org/10.1016/j.cell.2017.02.005
17 QLYing, JWray, JNichols, LBatlle-Morera, BDoble, JWoodgett, PCohen, ASmith (2008) The ground state of embryonic stem cell self-renewal. Nature 453:519–523
https://doi.org/10.1038/nature06968
18 HYu, CBorsotti, JNSchickel, SZhu, TStrowig, EEEynon, DFrleta, CGurer, AJMurphy, GDYancopouloset al. (2017) A novel humanized mouse model with significant improvement of classswitched, antigen-specific antibody production. Blood 129:959–969
https://doi.org/10.1182/blood-2016-04-709584
19 XYZhao, WLi, ZLv, LLiu, MTong, THai, JHao, CLGuo, QWMa, LWanget al. (2009) iPS cells produce viable mice through tetraploid complementation. Nature 461:86–90
https://doi.org/10.1038/nature08267
[1] PAC-0020-18168-DHK_suppl_1 Download
[1] Bohong Chen, Shengcheng Deng, Tianyu Ge, Miaoman Ye, Jianping Yu, Song Lin, Wenbin Ma, Zhou Songyang. Live cell imaging and proteomic profiling of endogenous NEAT1 lncRNA by CRISPR/Cas9-mediated knock-in[J]. Protein Cell, 2020, 11(9): 641-660.
[2] Si Wang, Zheying Min, Qianzhao Ji, Lingling Geng, Yao Su, Zunpeng Liu, Huifang Hu, Lixia Wang, Weiqi Zhang, Keiichiro Suzuiki, Yu Huang, Puyao Zhang, Tie-Shan Tang, Jing Qu, Yang Yu, Guang-Hui Liu, Jie Qiao. Rescue of premature aging defects in Cockayne syndrome stem cells by CRISPR/Cas9-mediated gene correction[J]. Protein Cell, 2020, 11(1): 1-22.
[3] Jiangtao Ren, Yangbing Zhao. Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9[J]. Protein Cell, 2017, 8(9): 634-643.
[4] Lixia Wang, Fei Yi, Lina Fu, Jiping Yang, Si Wang, Zhaoxia Wang, Keiichiro Suzuki, Liang Sun, Xiuling Xu, Yang Yu, Jie Qiao, Juan Carlos Izpisua Belmonte, Ze Yang, Yun Yuan, Jing Qu, Guang-Hui Liu. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs[J]. Protein Cell, 2017, 8(5): 365-378.
[5] Puping Liang,Yanwen Xu,Xiya Zhang,Chenhui Ding,Rui Huang,Zhen Zhang,Jie Lv,Xiaowei Xie,Yuxi Chen,Yujing Li,Ying Sun,Yaofu Bai,Zhou Songyang,Wenbin Ma,Canquan Zhou,Junjiu Huang. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes[J]. Protein Cell, 2015, 6(5): 363-372.
[6] Liping Deng,Ruotong Ren,Jun Wu,Keiichiro Suzuki,Juan Carlos Izpisua Belmote,Guang-Hui Liu. CRISPR/Cas9 and TALE: beyond cut and paste[J]. Protein Cell, 2015, 6(3): 157-159.
[7] Qing Xie,Julia Klesney-Tait,Kathy Keck,Corey Parlet,Nicholas Borcherding,Ryan Kolb,Wei Li,Lorraine Tygrett,Thomas Waldschmidt,Alicia Olivier,Songhai Chen,Guang-Hui Liu,Xiangrui Li,Weizhou Zhang. Characterization of a novel mouse model with genetic deletion of CD177[J]. Protein Cell, 2015, 6(2): 117-126.
[8] Jianhua Xiong. Atg7 in development and disease: panacea or Pandora’s Box?[J]. Protein Cell, 2015, 6(10): 722-734.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed